Kobayashi Pharmaceutical Co Ltd - Company Profile

Powered by

All the sales intelligence you need on Kobayashi Pharmaceutical Co Ltd in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Kobayashi Pharmaceutical Co Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Kobayashi Pharmaceutical Co Ltd.

Back to companies

Kobayashi Pharmaceutical Co Ltd: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Kobayashi Pharmaceutical Co Ltd (Kobayashi) manufactures and distributes pharmaceutical, health and personal care products. The company offers over the counter (OTC) pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, eyeglasses cleaners, body warmers and cooling gel sheets for the forehead. It also offers health food products, dietary food products, nutritional supplements, skincare products, medical equipment, devices and ventilators to medical institutes and hospitals. The company provides services that include transportation, insurance, production, advertising planning, synthetic resin products, and real estate management services. The company operates through subsidiaries and has a presence in Europe, North America, and Asia. Kobayashi is headquartered in Chuo, Osaka, Japan.

Gain a 360-degree view of Kobayashi Pharmaceutical Co Ltd and make more informed decisions for your business Gain a 360-degree view of Kobayashi Pharmaceutical Co Ltd and make more informed decisions for your business Learn more
Headquarters Japan

Address Kdx Kobayashi Doshomachi Bldg., 4-4-10, Dosho-Machi, Chuo-Ku, Osaka, 541-0045


No of Employees 3,731

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 4967 (TYO)

Revenue (2024) $1.1B -4.5% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ -50.5% (2024 vs 2023)

Market Cap* $2.7B

Net Profit Margin (2023) XYZ -48.2% (2024 vs 2023)

   

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Kobayashi Pharmaceutical Co Ltd premium industry data and analytics

15+

Marketed Drugs

Understand Kobayashi Pharmaceutical Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

13+

Clinical Trials

Determine Kobayashi Pharmaceutical Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

5

Catalyst Calendar

Proactively evaluate Kobayashi Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Kobayashi Pharmaceutical Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Pharmaceuticals Products Transportation Services AMMELTZ
Food Real Estate Management KOOLFEVER
Fragrances and Deodorizers Advertising Planning SAWADAY
XYZ XYZ XYZ
XYZ XYZ XYZ
XYZ XYZ XYZ
Understand Kobayashi Pharmaceutical Co Ltd portfolio and identify potential areas for collaboration Understand Kobayashi Pharmaceutical Co Ltd portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 New Products/Services In April, the company introduced the Salacia 100 Premium.
2026 Plans/Strategy In March, the company announced its plans to introduce Sarasa-T Cotton 100 for Thongs.
2026 Plans/Strategy In March, the company announced its plans to introduce a new line of toilet bowl cleaners, Bluelet Disinfectant EX Green Label Green Citrus.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters Kobayashi Pharmaceutical Co Ltd Taisho Pharmaceutical Holdings Co Ltd Rohto Pharmaceutical Co Ltd Santen Pharmaceutical Co Ltd Tsumura & Co
Headquarters Japan Japan Japan Japan Japan
City Osaka Toshima Osaka-Shi Osaka Minato
State/Province Osaka Tokyo Osaka Osaka Tokyo
No. of Employees 3,731 8,784 9,144 3,849 4,272
Entity Type Public Private Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Yoshihito Ota Chairman Executive Board 2025 -
Norikazu Toyoda Chief Executive Officer; President; Director Executive Board 2025 62
Toyoda Kaichi Director; President Executive Board 2025 -
Yuji Matsushima Director; Senior Managing Executive Officer; Head - Research and Development Division Executive Board 2025 -
Akihiro Kobayashi Executive Officer; Head - Compensation Response Division; Director Executive Board 2024 -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Kobayashi Pharmaceutical Co Ltd key executives to enhance your sales strategy Gain insight into Kobayashi Pharmaceutical Co Ltd key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?